Fred Alger Management »

Protagonist Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $938k 7.7k 122.58
2025-03-31 $362k 7.5k 48.36
2023-06-30 $600k 22k 27.62
2023-03-31 $267k 12k 23.00

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Amazon.com Equity (AMZN)
Nebius Group N.V. Class A Equity (NBIS)
Alphabet Inc. Class C Equity (GOOG)
Apple Equity (AAPL)
Western Digital Corporation Equity (WDC)
Meta Platforms Inc Class A Equity (META)
Broadcom Equity (AVGO)
Space Exploration Technologies Corp. Class A Equity (SPCX)
Tesla Equity (TSLA)
AppLovin Corp. Class A Equity (APP)
Astera Labs Equity (ALAB)
Talen Energy Corp Equity (TLN)
Natera Equity (NTRA)

View all positions for Fred Alger Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Portfolio Management
Wellington Management Company
UBS Group
State Street Corporation
Henderson Group
Vanguard Capital Management
Johnson & Johnson
Invesco
Jupiter Topco
Geode Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Protagonist Therapeutics